Michelle Gilson, CFO of Arcellx Inc (NASDAQ:ACLX), sold 12,877 shares on June 26, 2024, now owning 6,915 shares. The biotech company focuses on cell therapies for cancer and autoimmune diseases.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing